Haley J Appaneal1,2,3,4, Aisling R Caffrey1,2,3,4, Vrishali V Lopes1, Christopher J Crnich5,6, David M Dosa1,2,4, Kerry L LaPlante1,2,3,4,7. 1. Infectious Diseases Research Program, Providence Veterans' Affairs Medical Center, Providence, Rhode Island. 2. Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, Rhode Island. 3. College of Pharmacy, University of Rhode Island, Kingston, Rhode Island. 4. Brown University School of Public Health, Providence, Rhode Island. 5. William S. Middleton VA Hospital, Madison, Wisconsin. 6. University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. 7. Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, Rhode Island.
Abstract
OBJECTIVE: To describe urinary tract infection (UTI) treatment among Veterans' Affairs (VA) Community Living Centers (CLCs) nationally and to assess related trends in antibiotic use. DESIGN: Descriptive study. SETTING AND PARTICIPANTS: All UTI episodes treated from 2013 through 2017 among residents in 110 VA CLCs. UTI episodes required collection of a urine culture, antibiotic treatment, and a UTI diagnosis code. UTI episodes were stratified into culture-positive and culture-negative episodes. METHODS: Frequency and rate of antibiotic use were assessed for all UTI episodes overall and were stratified by culture-positive and culture-negative episodes. Joinpoint software was used for regression analyses of trends over time. RESULTS: We identified 28,247 UTI episodes in 14,983 Veterans. The average age of Veterans was 75.7 years, and 95.9% were male. Approximately half of UTI episodes (45.7%) were culture positive and 25.7% were culture negative. Escherichia coli was recovered in 34.1% of culture-positive UTI episodes, followed by Proteus mirabilis and Klebsiella spp, which were recovered in 24.5% and 17.4% of culture-positive UTI episodes, respectively. The rate of total antibiotic use in days of therapy (DOT) per 1,000 bed days decreased by 10.1% per year (95% CI, -13.6% to -6.5%) and fluoroquinolone use (ciprofloxacin or levofloxacin) decreased by 14.5% per year (95% CI, -20.6% to -7.8%) among UTI episodes overall. Similar reductions in rates of total antibiotic use and fluoroquinolone use were observed among culture-positive UTI episodes and among culture-negative UTI episodes. CONCLUSION: Over a 5-year period, antibiotic use for UTIs significantly decreased among VA CLCs, as did use of fluoroquinolones. Antibiotic stewardship efforts across VA CLCs should be applauded, and these efforts should continue.
OBJECTIVE: To describe urinary tract infection (UTI) treatment among Veterans' Affairs (VA) Community Living Centers (CLCs) nationally and to assess related trends in antibiotic use. DESIGN: Descriptive study. SETTING AND PARTICIPANTS: All UTI episodes treated from 2013 through 2017 among residents in 110 VA CLCs. UTI episodes required collection of a urine culture, antibiotic treatment, and a UTI diagnosis code. UTI episodes were stratified into culture-positive and culture-negative episodes. METHODS: Frequency and rate of antibiotic use were assessed for all UTI episodes overall and were stratified by culture-positive and culture-negative episodes. Joinpoint software was used for regression analyses of trends over time. RESULTS: We identified 28,247 UTI episodes in 14,983 Veterans. The average age of Veterans was 75.7 years, and 95.9% were male. Approximately half of UTI episodes (45.7%) were culture positive and 25.7% were culture negative. Escherichia coli was recovered in 34.1% of culture-positive UTI episodes, followed by Proteus mirabilis and Klebsiella spp, which were recovered in 24.5% and 17.4% of culture-positive UTI episodes, respectively. The rate of total antibiotic use in days of therapy (DOT) per 1,000 bed days decreased by 10.1% per year (95% CI, -13.6% to -6.5%) and fluoroquinolone use (ciprofloxacin or levofloxacin) decreased by 14.5% per year (95% CI, -20.6% to -7.8%) among UTI episodes overall. Similar reductions in rates of total antibiotic use and fluoroquinolone use were observed among culture-positive UTI episodes and among culture-negative UTI episodes. CONCLUSION: Over a 5-year period, antibiotic use for UTIs significantly decreased among VA CLCs, as did use of fluoroquinolones. Antibiotic stewardship efforts across VA CLCs should be applauded, and these efforts should continue.
Authors: Christine E Kistler; Sheryl Zimmerman; Kezia Scales; Kimberly Ward; David Weber; David Reed; Mallory McClester; Philip D Sloane Journal: J Am Geriatr Soc Date: 2017-03-28 Impact factor: 5.562
Authors: Nick Daneman; Susan E Bronskill; Andrea Gruneir; Alice M Newman; Hadas D Fischer; Paula A Rochon; Geoffrey M Anderson; Chaim M Bell Journal: JAMA Intern Med Date: 2015-08 Impact factor: 21.873
Authors: Thomas M Hooton; Suzanne F Bradley; Diana D Cardenas; Richard Colgan; Suzanne E Geerlings; James C Rice; Sanjay Saint; Anthony J Schaeffer; Paul A Tambayh; Peter Tenke; Lindsay E Nicolle Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: Rituparna Das; Eleanor Perrelli; Virginia Towle; Peter H Van Ness; Manisha Juthani-Mehta Journal: Infect Control Hosp Epidemiol Date: 2009-11 Impact factor: 3.254
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Infect Control Hosp Epidemiol Date: 2008-09 Impact factor: 3.254
Authors: Haley J Morrill; Aisling R Caffrey; Robin L P Jump; David Dosa; Kerry L LaPlante Journal: J Am Med Dir Assoc Date: 2016-01-06 Impact factor: 4.669
Authors: Charles D Phillips; Omolola Adepoju; Nimalie Stone; Darcy K McMaughan Moudouni; Obioma Nwaiwu; Hongwei Zhao; Elizabeth Frentzel; David Mehr; Steven Garfinkel Journal: BMC Geriatr Date: 2012-11-23 Impact factor: 3.921
Authors: H J Appaneal; A R Caffrey; V V Lopes; V Mor; D M Dosa; K L LaPlante; T I Shireman Journal: J Hosp Infect Date: 2021-02-05 Impact factor: 3.926
Authors: Haley J Appaneal; Theresa I Shireman; Vrishali V Lopes; Vincent Mor; David M Dosa; Kerry L LaPlante; Aisling R Caffrey Journal: BMC Geriatr Date: 2021-07-23 Impact factor: 3.921